Selective postoperative radioactive iodine treatment of thyroid carcinoma
β Scribed by Christopher McHenry; Harriet Jarosz; Melva Davis; A. L. Barbate; A. M. Lawrence; E. Paloyan
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 383 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Radioactive iodineβrefractory (RAIR) 18Fβfluorodeoxyglucose (FDG)βpositron emission tomography (PET) positive thyroid carcinomas represent the major cause of deaths from thyroid carcinomas (TC) and are therefore the main focus of novel target therapies. However, to the a
BACKGROUND. Among patients with well differentiated papillary thyroid carcinoma who generally have an excellent prognosis and a near-normal lifespan, there exist subsets of patients who have significant risk for morbidity and mortality from this disease. It is important to define the patterns of dis
## Abstract ## Background. In wellβdifferentiated thyroid carcinoma, predictors of future positivity of stimulated thyroglobulin (>2 ΞΌg/L) after initial radioactive iodine treatment are not known. ## Methods. In a retrospective study, we used logistic regression analysis to determine whether pos